Related to Synedgen Wins $2.73M U.S. Army Grant to Combat Drug-Resistant Bacteria

• Collaboration Formed to Evaluate Epigenomics’ Test in Detecting Colorectal Polyps
  
• Scientists Reveal E. coli’s Survival Technique
  
• Charley's Fund Adds $3M in Research Support for AVI’s Therapy for Duchenne Muscular Dystrophy
  
• Scientists Pinpoint Enzyme Involved in Resistance to Childhood Leukemia Drug
  
• NIDA Gives Albert Einstein College $3M to Study HIV-Related Brain Disease
  
• Quest Diagnostics Launches HIV Test to Determine Patients Suitable for Entry Inhibitors
  
• UK HIV Vaccine Consortium Orders Candidate Genes from Geneart
  
• CIRM Bankrolls 15 Stem Cell Research Grants with $40M
  
• NIH Doles Out $42M to Bolster the Human Microbiome Project
  
• Israeli Government Boosts Compugen Drug Discovery Funding with $400K
  
• Fast-Track and Atox Score $575K Grant to Move Septic Shock Treatment into Clinic
  
• Tamoxifen Resistance Linked to Heightened Growth Factor Signaling
  
• Morphotek Taps Synageva in Cancer and Infectious Disease Deal
  
• NIH Sets Guidelines for Funding Research on Human Stem Cells
  
• NIH Bankrolls $10M for Albert Einstein College of Medicine to Study Motion-Induced Enzyme Changes
  
• Human Genome Sciences Receives $151M Order for Anthrax Drug from U.S. Government
  
• University of Rhode Island Wins $13M Grant to Develop Vaccines for Emerging Infectious Diseases
  
• Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders
  
• Crucell and PATH Malaria Vaccine Program Get Funding to Develop a Prime-Boost Adenoviral Vaccine
  
• Apogenix Obtains Roughly $3.66M to Further Cancer and Inflammatory Disease Initiatives